Jenburkt Pharmaceuticals P/E Ratio
JENBURPH • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
13.71
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
13.71
Current Price
₹1012.95
EPS (TTM)
₹72.65
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
47.4
Sector Median
26.0
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Jenburkt Pharmaceuticals
- Stock appears undervalued with PE of 13.71, suggesting potential buying opportunity
- Trading at discount to sector average PE of 47.4
Related Pages for Jenburkt Pharmaceuticals
Additional stock information and data for JENBURPH
Sector P/E Ratio Comparison
Comparing Jenburkt Pharmaceuticals with other companies in Healthcare sector
Sector Average
47.4
Sector Median
26.0
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.9 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.48 | ₹1,128 | Low |
| Amwill Health Care | AMWILL | 5.98 | ₹61 | Low |
| Medicamen Organics | MEDIORG | 6.37 | ₹25 | Low |
| Brooks Laboratories | BROOKS | 6.41 | ₹127 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.14 | ₹2,000 | Low |
| Zenith Drugs | ZENITHDRUG | 7.28 | ₹65 | Low |
| Galaxy Medicare | GML | 7.77 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.19 | ₹34 | Low |